New opportunities on the horizon as TSS expands US operations

We are expanding our US operations, with Evan Hahn to be the new VP North America. Evan brings a wealth of knowledge of the pharmaceutical clinical trial space, supporting the TSS launch of its new offering in this category.
TSS recently appointed of Evan Hahn as VP of North America to lead expansion in the strategic US life sciences market.

TSS expands US operations

Evan brings extensive expertise and over 20 years of experience applying innovative approaches to life sciences through a combination of technology and sophisticated applications of data, driving insights and efficiency in clinical development.

Before joining TSS, Evan led the growth of Medidata’s Randomization and Trial Supply software solution (RTSM) from product startup to an industry leader. At Cytel, he promoted the adoption of adaptive trial designs and drug supply forecasting. Across both organizations, he met with 100s of supply chain leaders globally, gaining broad insights into the challenges they face, receiving feedback from large pharma, startup biotechs, CROs, and regulatory agencies such as the FDA and NCI on biopharma supply challenges.

Evan explains the reason for his move to TSS: “Temperature monitoring plays a vital role in the drugs delivery cycle – and TSS is at the cutting edge of ensuring the delivery of safe and sustainable therapies to patients. I’m passionately committed to bringing innovative approaches to developing and delivering treatments and see tremendous opportunities to harness supply chain data into actionable insights – opportunities that are currently under-realized within biopharma.”

TSS’s technology-agnostic cloud platform is a ‘best in class’ solution that enables companies to transform their supply chain, by allowing for the ingestion and aggregation of data from disparate sources across that chain, providing end-to-end visibility and enabling direct to patient clinical trials while ensuring patient safety. Through advanced analytics and visualization of data we let users proactively address issues before they occur. With our Clinical Module, TSS is uniquely positioned to automate manual temperature excursion handling processes, and as such reduce burden for clinical sites and sponsor companies, while contributing to corporate sustainability goals.

For further information, please contact Matias Rodriguez, Head of Marketing. matias.rodriguez@tss.se

You may also be interested in

Mind the gap: the real-world impact of data gaps in clinical trials

Although clinical trials can cover a huge range of formats, from small academic assessments to global, multi-billion dollar ventures, they all have one thing in common. Their success (or failure) is determined by a consistent approach to data.
Read moreDownload Whitepaper
TSS logo.

TSS Welcomes Thomas Lindén as New Chief Technology Officer

TSS, a leading temperature monitoring solutions provider, is pleased to announce the appointment of Thomas Lindén as its new Chief Technology Officer (CTO). In this role, Thomas Lindén will play a crucial part in shaping the company's technological landscape and driving its growth strategies.
Read moreDownload Whitepaper
A TSS banner for LogiPharma Lyon 2024, showcasing automated temperature monitoring solutions for the pharmaceutical industry.

LogiPharma Lyon 2024

The Future of Temperature Monitoring: How to lower the CO2 footprint with a Circular Supply Solution
Read moreDownload Whitepaper

You may also be interested in

TSS Sponsors the 27th Annual Clinical Trial Supply Europe 2026 in Barcelona

TSS is proud to sponsor the 27th Annual Clinical Trial Supply Europe, taking place 24–25 February 2026 in Barcelona, Spain. The event brings together clinical supply professionals, sponsors, CROs, and solution providers to discuss how to strengthen resilience, quality, and patient safety across the clinical trial supply chain.
Read more

Can You Rely on the Results from Your Clinical Trials?

The success of a clinical trial depends on the reliability of its data. Many investigational drugs are sensitive to temperature, and any temperature deviation can affect their quality and, in the worst case, patient safety. Automated and integrated temperature monitoring solutions help secure data quality, support compliance, and speed up the delivery of new medicines to patients.
Read more

Subscribe to our newsletter

Sign up for our newsletter to receive all the latest TSS news and insights in temperature management solutions.